Outlook Therapeutics (OTLK) Assets: 2015-2020
Historic Assets for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $30.2 million.
- Outlook Therapeutics' Assets fell 8.95% to $30.2 million in Q2 2020 from the same period last year, while for Jun 2020 it was $30.2 million, marking a year-over-year decrease of 8.95%. This contributed to the annual value of $17.1 million for FY2019, which is 23.10% down from last year.
- According to the latest figures from Q2 2020, Outlook Therapeutics' Assets is $30.2 million, which was up 129.64% from $13.2 million recorded in Q1 2020.
- Over the past 5 years, Outlook Therapeutics' Assets peaked at $34.1 million during Q2 2018, and registered a low of $10.4 million during Q4 2019.
- Its 3-year average for Assets is $22.4 million, with a median of $20.5 million in 2018.
- Per our database at Business Quant, Outlook Therapeutics' Assets tumbled by 48.09% in 2017 and then skyrocketed by 99.02% in 2018.
- Outlook Therapeutics' Assets (Quarterly) stood at $20.4 million in 2016, then skyrocketed by 57.86% to $32.3 million in 2017, then crashed by 42.03% to $18.7 million in 2018, then tumbled by 44.29% to $10.4 million in 2019, then decreased by 8.95% to $30.2 million in 2020.
- Its last three reported values are $30.2 million in Q2 2020, $13.2 million for Q1 2020, and $10.4 million during Q4 2019.